Addendum 3 June 2024

We are pleased to announce the online publication of the update to the 2016 collaborative BSG/ESGE guideline on endoscopy in patients on antiplatelet or anticoagulant therapy.

An extensive revision, and evidence-based update, has been conducted throughout, and a section has been added on the management of patients presenting with acute GI haemorrhage.

As well as gastroenterologists, the authors include haematologists with expertise in thrombosis, an interventional cardiologist, and strong patient representation.

As before, recommendations are based on the risk balance between thrombosis and haemorrhage in given situations.

Andy Veitch
BSG President Elect 2020-2022

Supporting documents
Figure 1: Guidelines for the management of patients on P2Y12 receptor antagonist antiplatelet agents undergoing endoscopic procedures: 2021 update
Figure 2: Guidelines for the management of patients on warfarin or Direct Oral Anticoagulants (DOAC) undergoing endoscopic procedures: 2021 update
Patient Information